Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Exchange Rate Effect: 2016-2024

Historic Exchange Rate Effect for Ultragenyx Pharmaceutical (RARE) over the last 9 years, with Dec 2024 value amounting to -$2.5 million.

  • Ultragenyx Pharmaceutical's Exchange Rate Effect fell 76.94% to $294,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 107.71%. This contributed to the annual value of -$2.5 million for FY2024, which is 646.54% down from last year.
  • Latest data reveals that Ultragenyx Pharmaceutical reported Exchange Rate Effect of -$2.5 million as of FY2024, which was down 646.54% from $462,000 recorded in FY2023.
  • In the past 5 years, Ultragenyx Pharmaceutical's Exchange Rate Effect registered a high of $1.1 million during FY2020, and its lowest value of -$2.5 million during FY2024.
  • For the 3-year period, Ultragenyx Pharmaceutical's Exchange Rate Effect averaged around -$1.0 million, with its median value being -$1.1 million (2022).
  • In the last 5 years, Ultragenyx Pharmaceutical's Exchange Rate Effect spiked by 778.18% in 2020 and then tumbled by 646.54% in 2024.
  • Over the past 5 years, Ultragenyx Pharmaceutical's Exchange Rate Effect (Yearly) stood at $1.1 million in 2020, then plummeted by 206.70% to -$1.2 million in 2021, then increased by 9.97% to -$1.1 million in 2022, then surged by 142.98% to $462,000 in 2023, then plummeted by 646.54% to -$2.5 million in 2024.